The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): Experiences from Hong Kong

Influenza and other Respiratory Viruses

Volumn 7, Issue 3, 2013, Pages 367-382

  Wu, Peng ^a   Cowling, Benjamin J ^a   Wu, Joseph T ^a   Lau, Eric H Y ^a   Ip, Dennis K M ^a   Nishiura, Hiroshi ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ARTICLE; HONG KONG; HUMAN; INFECTION CONTROL; INFLUENZA A (H1N1); MEDICAL RESEARCH; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PUBLIC HEALTH; SYSTEMATIC REVIEW; VIRUS TRANSMISSION;

HONG KONG; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PANDEMICS; PUBLIC HEALTH;

EID: 84876487880     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2012.00420.x     Document Type: Article

References (70)

1. Leung GM, Nicoll A. Reflections on pandemic (H1N1) 2009 and the international response. PLoS Med 2010; 7:e1000346.
2. Ferguson NM, Cummings DAT, Cauchemez S et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005; 437:209-214.
3. Cooper BS, Pitman RJ, Edmunds WJ, Gay NJ. Delaying the international spread of pandemic influenza. PLoS Med 2006; 3:e212.
4. Coleman MT, Dowdle WR, Pereira HG, Schild GC, Chang WK. The Hong Kong-68 influenza A2 variant. Lancet 1968; 2:1384-1386.
5. Claas ECJ, de JongJC, van BeekR, Rimmelzwaan GF, Osterhaus ADME. Human influenza virus A/Hong Kong/156/97 (H5N1) infection. Vaccine 1998; 16:977-978.
6. Yang L, Chan KP, Cowling BJ et al. Excess mortality associated with the 2009 pandemic of influenza A(H1N1) in Hong Kong. Epidemiol Infect 2012; PMID:22074735
7. Wu JT, Ma ES, Lee CK et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010; 51:1184-1191.
8. Wu JT, Ho A, Ma ESK et al. Estimating Infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data. PLoS Med 2011; 8:e1001103.
9. Wu JT, Cowling BJ, Lau EH et al. School closure and mitigation of pandemic (H1N1) 2009, Hong Kong. Emerg Infect Dis 2010; 16:538-541.
10. Cowling BJ, Lau MS, Ho LM et al. The effective reproduction number of pandemic influenza: prospective estimation. Epidemiology 2010; 21:842-846.
11. Zhang AJ, To KK, Tse H et al. High incidence of severe influenza among individuals aged over 50years. Clin Vaccine Immunol 2011; 18:1918-1924.
12. Klick B, Nishiura H, Ng S et al. Transmissibility of seasonal and pandemic influenza in a cohort of households in Hong Kong in 2009. Epidemiology 2011; 22:793-796.
13. Leung YH, Li MP, Chuang SK. A school outbreak of pandemic (H1N1) 2009 infection: assessment of secondary household transmission and the protective role of oseltamivir. Epidemiol Infect 2011; 139:41-44.
14. Lee SS, Wong NS. Characterizing the initial diffusion pattern of pandemic (H1N1) 2009 using surveillance data. PLoS Curr 2010; 2:RRN1151.
15. Lee SS, Wong NS. The clustering and transmission dynamics of pandemic influenza A (H1N1) 2009 cases in Hong Kong. J Infect 2011; 63:274-280.
16. Lee SS, Wong NS. Reconstruction of epidemic curves for pandemic influenza A (H1N1) 2009 at city and sub-city levels. Virol J 2010; 7:321.
17. Seto WH, Cowling BJ, Lam HS, Ching PT, To ML, Pittet D. Clinical and nonclinical health care workers faced a similar risk of acquiring 2009 pandemic H1N1 infection. Clin Infect Dis 2011; 53:280-283.
18. Cowling BJ, Chan KH, Fang VJ et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362:2175-2184.
19. Riley S, Kwok KO, Wu KM et al. Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med 2011; 8:e1000442.
20. Chan JF, To KK, Tse H et al. The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation. Clin Vaccine Immunol 2011; 18:305-310.
21. Lee N, Chan PK, Wong CK et al. Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia. Antivir Ther 2011; 16:237-247.
22. Zhou Y, Ng DM, Seto WH et al. Seroprevalence of antibody to pandemic influenza A (H1N1) 2009 among healthcare workers after the first wave in Hong Kong. J Hosp Infect 2011; 78:308-311.
23. To KK, Chan KH, Li IW et al. Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol 2010; 82:1-7.
24. To KK, Wong SS, Li IW et al. Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection. Postgrad Med J 2010; 86:515-521.
25. Chiu SS, Chan KH, Wong WH, Chan EL, Peiris JS. Age-matched comparison of children hospitalized for 2009 pandemic H1N1 influenza with those hospitalized for seasonal H1N1 and H3N2. PLoS One 2011; 6:e21837.
26. Mak GC, Choy PW, Lee WY, Wong AH, Ng KC, Lim W. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong. J Med Virol 2010; 82:1809-1815.
27. Lei T, Siu K-L, Kok K-H et al. Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus. Vaccine 2012; 30:2605-2610.
28. Liao Q, Cowling BJ, Lam WW, Fielding R. The influence of social-cognitive factors on personal hygiene practices to protect against influenzas: using modelling to compare avian A/H5N1 and 2009 pandemic A/H1N1 influenzas in Hong Kong. Int J Behav Med 2011; 18:93-104.
29. Siu JY. Another nightmare after SARS: knowledge perceptions of and overcoming strategies for H1N1 influenza among chronic renal disease patients in Hong Kong. Qual Health Res 2010; 20:893-904.
30. Cowling BJ, Ng DM, Ip DK et al. Community psychological and behavioral responses through the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong. J Infect Dis 2010; 202:867-876.
31. Lau JT, Griffiths S, Choi KC, Tsui HY. Widespread public misconception in the early phase of the H1N1 influenza epidemic. J Infect 2009; 59:122-127.
32. Lau JT, Griffiths S, Choi KC, Lin C. Prevalence of preventive behaviors and associated factors during early phase of the H1N1 influenza epidemic. Am J Infect Control 2010; 38:374-380.
33. Lau JT, Griffiths S, Au DW, Choi KC. Changes in knowledge, perceptions, preventive behaviours and psychological responses in the pre-community outbreak phase of the H1N1 epidemic. Epidemiol Infect 2011; 139:80-90.
34. Lau JT, Griffiths S, Choi KC, Tsui HY. Avoidance behaviors and negative psychological responses in the general population in the initial stage of the H1N1 pandemic in Hong Kong. BMC Infect Dis 2010; 10:139.
35. Wong EM, Cheng MM, Lo SK. Teachers' risk perception and needs in addressing infectious disease outbreak. J Sch Nurs 2010; 26:398-406.
36. Griffiths SM, Wong AH, Kim JH, Yung TK, Lau JT. Influence of country of study on student responsiveness to the H1N1 pandemic. Public Health 2010; 124:460-466.
37. Liao Q, Cowling B, Lam WT, Ng MW, Fielding R. Situational awareness and health protective responses to pandemic influenza A (H1N1) in Hong Kong: a cross-sectional study. PLoS One 2010; 5:e13350.
38. Wong EL, Wong SY, Lee N, Cheung A, Griffiths S. Healthcare workers' duty concerns of working in the isolation ward during the novel H1N1 pandemic. J Clin Nurs 2011; 21:1466-1475.
39. Wong EL, Wong SY, Kung K, Cheung AW, Gao TT, Griffiths S. Will the community nurse continue to function during H1N1 influenza pandemic: a cross-sectional study of Hong Kong community nurses?BMC Health Serv Res 2010; 10:107.
40. Wong SY, Wong EL, Chor J et al. Willingness to accept H1N1 pandemic influenza vaccine: a cross-sectional study of Hong Kong community nurses. BMC Infect Dis 2010; 10:316.
41. Lau JT, Yeung NC, Choi KC, Cheng MY, Tsui HY, Griffiths S. Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey. Br Med J 2009; 339:b4164.
42. Lau JT, Yeung NC, Choi KC, Cheng MY, Tsui HY, Griffiths S. Factors in association with acceptability of A/H1N1 vaccination during the influenza A/H1N1 pandemic phase in the Hong Kong general population. Vaccine 2010; 28:4632-4637.
43. Siu JY. The perceptions of and disincentives for receiving influenza A (H1N1) vaccines among chronic renal disease patients in Hong Kong. Health Soc Care Community 2011; 20:137-144.
44. Liao Q, Cowling BJ, Lam WW, Fielding R. Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: a longitudinal study. PLoS One 2011; 6:e17713.
45. Chor JS, Ngai KL, Goggins WB et al. Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. Br Med J 2009; 339:b3391.
46. Chor JS, Pada SK, Stephenson I et al. Seasonal influenza vaccination predicts pandemic H1N1 vaccination uptake among healthcare workers in three countries. Vaccine 2011; 29:7364-7369.
47. Mak KK, Lai CM. Knowledge, risk perceptions, and preventive precautions among Hong Kong students during the 2009 influenza A (H1N1) pandemic. Am J Infect Control 2012; 40:273-275.
48. Mak GC, Wong AH, Ho WYY, Lim W. The impact of pandemic influenza A (H1N1) 2009 on the circulation of respiratory viruses 2009-2011. Influenza Other Respir Viruses 2012; 6:e6-e10.
49. Tarrant M, Wu K, Yuen C, Cheung K, Chan V. Determinants of 2009 A/H1N1 influenza vaccination among pregnant women in Hong Kong. Matern Child Health J 2012; doi: 10.1007/s10995-011-0943-1.
50. Li IW, Hung IF, To KK et al. The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment. Chest 2010; 137:759-768.
51. Leung YH, Lim WL, Wong MH, Chuang SK. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus. Epidemiol Infect 2012; 140:814-817.
52. You JHS, Chan ESK, Leung MYK, Ip M, Lee NLS. A cost-effectiveness analysis of "Test" versus "Treat" patients hospitalized with suspected influenza in Hong Kong. PLoS One 2012; 7:e33123.
53. Cowling BJ, Ng S, Ma ES et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis 2010; 51:1370-1379.
54. Chan TC, Hung IFN, Luk JKH et al. Efficacy of dual vaccination of pandemic H1N1 2009 influenza and seasonal influenza on institutionalized elderly: a one-year prospective cohort study. Vaccine 2011; 29:7773-7778.
55. Wong HK, Lee CK, Hung IF et al. Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection. Transfusion 2010; 50:1967-1971.
56. Hung IF, To KK, Lee CK et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 2011; 52:447-456.
57. Wu JT, Lee CK, Cowling BJ, Yuen KY. Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic. Proc Nat Acad Sci USA 2010; 107:3269-3274.
58. Cheng VCC, Tai JWM, Wong LMW et al. Prevention of nosocomial transmission of swine-origin pandemic influenza virus A/H1N1 by infection control bundle. J Hosp Infect 2010; 74:271-277.
59. Cowling BJ, Lau LL, Wu P et al. Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1). BMC Infect Dis 2010; 10:82.
60. Chan KK, Lee KL, Lam PK, Law KI, Joynt GM, Yan WW. Hong Kong's experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1). Hong Kong Med J 2010; 16:447-454.
61. Boëlle P, Ansart S, Cori A, Valleron A. Transmission parameters of the A/H1N1 (2009) influenza virus pandemic: a review. Influenza Other Respir Viruses 2011; 5:306-316.
62. Hiroshi N. Case fatality ratio of pandemic influenza. Lancet Infect Dis 2010; 10:443-444.
63. Presanis AM, De Angelis D, Hagy A et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 2009; 6:e1000207.
64. Wong C-M, Chan K-P, Hedley AJ, Peiris JSM. Influenza-associated mortality in Hong Kong. Clin Infect Dis 2004; 39:1611-1617.
65. Smith GJD, Vijaykrishna D, Bahl J et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009; 459:1122-1125.
66. Chan MCW, Chan RWY, Yu WCL et al. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 2010; 176:1828-1840.
67. Lipsitch M, Hayden FG, Cowling BJ, Leung GM. How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count. Lancet 2009; 374:1209-1211.
68. McLean E, Pebody RG, Campbell C et al. Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect 2010; 138:1531-1541.
69. Giesecke J. Modern infectious disease epidemiology. London: Edward Arnold, 1994.
70. Lee N, Chan PK, Lui GC et al. Complications and outcomes of pandemic 2009 Influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza?J Infect Dis 2011; 203:1739-1747.